Toronto Dominion Bank
ASBPW

Toronto Dominion Bank’s Aspire Biopharma Warrant ASBPW Stock Holding History

Toronto Dominion Bank’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Sell
516,245
-100
-0% -$2 ﹤0.01% 2089
2026
Q1 		$8.78K Sell
516,345
-100
-0% -$2 ﹤0.01% 1941
2025
Q4 		$8.26K Sell
516,445
-500
-0.1% -$15 ﹤0.01% 1835
2025
Q3 		$15.5K Buy
516,945
+100
+0% +$5 ﹤0.01% 1726
2025
Q2 		$23.1K Buy
+516,845
New +$25.5K ﹤0.01% 1562

Other funds holding ASBPW

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Toronto Dominion Bank's ASBPW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Aspire Biopharma Warrant (ASBPW) stake by 0.02% in Q2 2026, selling an estimated $2 and leaving 516,245 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Toronto Dominion Bank first reported a position in ASBPW in Q2 2025 and has held it in 5 quarters since. The position peaked at $23.1K in Q2 2025. 27 funds tracked by Wall St. Rank hold ASBPW as of Q2 2026.

  • Toronto Dominion Bank held 516,245 shares of Aspire Biopharma Warrant worth $10.3K as of Q2 2026.
  • Toronto Dominion Bank sold 100 Aspire Biopharma Warrant shares in Q2 2026, an estimated $2.
  • Aspire Biopharma Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2089 holding.
  • Toronto Dominion Bank first reported a position in Aspire Biopharma Warrant in Q2 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Aspire Biopharma Warrant position peaked at $23.1K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.